PREDNISOLONE

PREDNISOLONE was reported 182696 times

PREDNISOLONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ALVEOLAR PROTEINOSIS 189 0.3193
1 PARVOVIRUS B19 INFECTION 275 0.3073
2 C-REACTIVE PROTEIN 269 0.2902
3 PULMONARY NOCARDIOSIS 238 0.2888
4 DEEP VEIN THROMBOSIS POSTOPERATIVE 550 0.2746
5 STEROID DIABETES 402 0.2678
6 POLYOMAVIRUS VIRAEMIA 264 0.2486
7 HEPATITIS E 389 0.2462
8 STRONGYLOIDIASIS 389 0.2406
9 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 538 0.2294
10 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 153 0.2290
11 PNEUMOCYSTIS JIROVECI PNEUMONIA 509 0.2283
12 MYCOBACTERIUM CHELONAE INFECTION 166 0.2246
13 NOCARDIOSIS 557 0.2176
14 DISSEMINATED CRYPTOCOCCOSIS 150 0.1982
15 COMPLICATIONS OF TRANSPLANTED KIDNEY 446 0.1965
16 CYTOMEGALOVIRUS ENTEROCOLITIS 151 0.1961
17 DELAYED GRAFT FUNCTION 137 0.1927
18 CYTOMEGALOVIRUS COLITIS 443 0.1924
19 VARICELLA ZOSTER VIRUS INFECTION 399 0.1923
20 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 181 0.1911
21 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 972 0.1908
22 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 337 0.1905
23 INFECTION IN AN IMMUNOCOMPROMISED HOST 134 0.1866
24 X-RAY ABNORMAL 330 0.1844
25 INFECTION REACTIVATION 209 0.1825
26 LUPUS VULGARIS 227 0.1802
27 JC VIRUS INFECTION 286 0.1787
28 PNEUMOCYSTIS JIROVECII PNEUMONIA 1781 0.1772
29 LYMPHOPROLIFERATIVE DISORDER 520 0.1769
30 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 206 0.1717
31 CHRONIC ALLOGRAFT NEPHROPATHY 133 0.1699
32 SWOLLEN JOINT COUNT INCREASED 527 0.1651
33 TRANSPLANT REJECTION 1323 0.1650
34 CRYPTOCOCCOSIS 267 0.1637
35 VIRAEMIA 224 0.1616
36 BK VIRUS INFECTION 542 0.1605
37 TRANSPLANT DYSFUNCTION 286 0.1601
38 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 210 0.1595
39 KIDNEY TRANSPLANT REJECTION 761 0.1584
40 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 327 0.1577
41 STEROID DEPENDENCE 138 0.1572
42 CYTOMEGALOVIRUS INFECTION 2605 0.1566
43 PNEUMONIA CYTOMEGALOVIRAL 301 0.1548
44 MENINGITIS CRYPTOCOCCAL 269 0.1537
45 CYTOMEGALOVIRUS TEST POSITIVE 270 0.1513
46 ATYPICAL MYCOBACTERIAL INFECTION 212 0.1498
47 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 495 0.1497
48 LUPUS NEPHRITIS 280 0.1496
49 RHEUMATIC FEVER 663 0.1486
50 FACET JOINT SYNDROME 483 0.1482
51 PNEUMONIA CRYPTOCOCCAL 140 0.1481
52 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 326 0.1477
53 CUSHINGOID 473 0.1472
54 PNEUMOCYSTIS JIROVECII INFECTION 174 0.1456
55 DISLOCATION OF VERTEBRA 332 0.1454
56 EPSTEIN-BARR VIRUS INFECTION 906 0.1449
57 CYTOMEGALOVIRUS CHORIORETINITIS 281 0.1440
58 UPPER RESPIRATORY TRACT INFLAMMATION 171 0.1425
59 BRAIN ABSCESS 355 0.1402
60 SUBCUTANEOUS EMPHYSEMA 136 0.1385
61 HYPOFIBRINOGENAEMIA 137 0.1381
62 CYTOMEGALOVIRUS INFECTION REACTIVATION 610 0.1379
63 RETINITIS 237 0.1371
64 CYTOMEGALOVIRUS VIRAEMIA 609 0.1368
65 LIVER TRANSPLANT REJECTION 245 0.1363
66 EPSTEIN-BARR VIRAEMIA 150 0.1353
67 CHORIORETINOPATHY 190 0.1334
68 MUCORMYCOSIS 347 0.1334
69 BRONCHOPULMONARY ASPERGILLOSIS 1034 0.1332
70 OBLITERATIVE BRONCHIOLITIS 171 0.1302
71 DISSEMINATED TUBERCULOSIS 334 0.1301
72 PNEUMOMEDIASTINUM 235 0.1299
73 HEPATITIS B REACTIVATION 411 0.1294
74 STEROID WITHDRAWAL SYNDROME 132 0.1292
75 SECONDARY IMMUNODEFICIENCY 155 0.1276
76 LISTERIOSIS 139 0.1257
77 DUODENAL ULCER PERFORATION 930 0.1249
78 MYCOBACTERIAL INFECTION 215 0.1247
79 ADENOVIRUS INFECTION 358 0.1233
80 DIFFUSE LARGE B-CELL LYMPHOMA 939 0.1217
81 ASPERGILLUS INFECTION 790 0.1202
82 SYSTEMIC MYCOSIS 140 0.1199
83 PORPHYRIA ACUTE 171 0.1192
84 PERIPHERAL VENOUS DISEASE 479 0.1172
85 HISTIOCYTOSIS HAEMATOPHAGIC 340 0.1144
86 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 810 0.1129
87 C-REACTIVE PROTEIN ABNORMAL 724 0.1128
88 CENTRAL NERVOUS SYSTEM LYMPHOMA 155 0.1124
89 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 251 0.1122
90 RHEUMATOID FACTOR POSITIVE 645 0.1116
91 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 308 0.1113
92 TRANSPLANT FAILURE 268 0.1092
93 ASPERGILLOSIS 139 0.1064
94 PNEUMATOSIS INTESTINALIS 296 0.1037
95 CHRONIC GRAFT VERSUS HOST DISEASE 373 0.1032
96 HEPATITIS B 622 0.1031
97 SYSTEMIC CANDIDA 249 0.0991
98 GRAFT VERSUS HOST DISEASE IN SKIN 217 0.0984
99 HYPOGAMMAGLOBULINAEMIA 646 0.0982
100 HELICOBACTER INFECTION 1001 0.0973
101 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 719 0.0957
102 SYSTEMIC INFECTION 158 0.0952
103 MUSCLE INJURY 779 0.0939
104 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 199 0.0934
105 KLEBSIELLA INFECTION 471 0.0930
106 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 762 0.0923
107 PULMONARY TUBERCULOSIS 394 0.0921
108 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 146 0.0911
109 BACTERIAL SEPSIS 293 0.0899
110 NEUTROPENIC SEPSIS 635 0.0888
111 ENTEROCOCCAL INFECTION 426 0.0881
112 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 571 0.0878
113 INFECTIOUS PLEURAL EFFUSION 132 0.0867
114 FOLLICULITIS 897 0.0855
115 LUNG ABSCESS 179 0.0852
116 THROMBOTIC MICROANGIOPATHY 817 0.0838
117 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 798 0.0835
118 PYODERMA GANGRENOSUM 294 0.0816
119 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 166 0.0813
120 OPPORTUNISTIC INFECTION 148 0.0800
121 PEMPHIGUS 995 0.0795
122 ATYPICAL FEMUR FRACTURE 224 0.0793
123 PYELONEPHRITIS ACUTE 155 0.0790
124 LOW BIRTH WEIGHT BABY 624 0.0785
125 STAPHYLOCOCCAL SEPSIS 386 0.0781
126 PANNICULITIS 188 0.0776
127 PSEUDOMONAS INFECTION 665 0.0775
128 ESCHERICHIA INFECTION 635 0.0771
129 IMMUNOSUPPRESSION 675 0.0764
130 OSTEOPOROTIC FRACTURE 146 0.0762
131 ORGANISING PNEUMONIA 378 0.0762
132 APLASIA PURE RED CELL 258 0.0749
133 LIP DRY 681 0.0749
134 ESCHERICHIA BACTERAEMIA 176 0.0748
135 RHEUMATOID NODULE 206 0.0747
136 ACUTE GRAFT VERSUS HOST DISEASE 342 0.0746
137 ARTHRITIS BACTERIAL 306 0.0745
138 LUNG CONSOLIDATION 208 0.0743
139 SMALL INTESTINAL PERFORATION 138 0.0735
140 HAND DEFORMITY 949 0.0723
141 HUMAN HERPESVIRUS 6 INFECTION 136 0.0719
142 DRUG TOLERANCE DECREASED 201 0.0715
143 GRAFT VERSUS HOST DISEASE 514 0.0714
144 NEPHROTIC SYNDROME 484 0.0705
145 OCULAR HYPERTENSION 137 0.0705
146 PNEUMONIA FUNGAL 275 0.0696
147 DISSEMINATED INTRAVASCULAR COAGULATION 972 0.0690
148 OESOPHAGEAL CANDIDIASIS 275 0.0689
149 HERPES SIMPLEX 436 0.0670
150 B-CELL LYMPHOMA 223 0.0656
151 PNEUMONIA BACTERIAL 602 0.0655
152 HAEMOLYTIC URAEMIC SYNDROME 151 0.0651
153 ESCHERICHIA SEPSIS 186 0.0641
154 MYCOBACTERIUM AVIUM COMPLEX INFECTION 172 0.0640
155 PERICARDITIS 1059 0.0630
156 ACTINIC KERATOSIS 160 0.0616
157 SYNOVITIS 1110 0.0615
158 STAPHYLOCOCCAL BACTERAEMIA 264 0.0607
159 BREAST CANCER STAGE III 393 0.0606
160 WOUND INFECTION 664 0.0606
161 AUTOIMMUNE DISORDER 590 0.0605
162 FOETAL GROWTH RESTRICTION 364 0.0598
163 LIVE BIRTH 499 0.0596
164 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 295 0.0591
165 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1664 0.0587
166 ESCHERICHIA URINARY TRACT INFECTION 248 0.0583
167 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 154 0.0579
168 BURSITIS 696 0.0573
169 BONE EROSION 198 0.0559
170 COVID-19 PNEUMONIA 661 0.0559
171 ENTEROCOLITIS 322 0.0557
172 BRONCHOPNEUMONIA 187 0.0546
173 LYMPHOPENIA 771 0.0545
174 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 208 0.0544
175 TUMOUR LYSIS SYNDROME 479 0.0544
176 BLOOD IMMUNOGLOBULIN G DECREASED 134 0.0540
177 ENDOCARDITIS 277 0.0540
178 RED BLOOD CELL SEDIMENTATION RATE INCREASED 594 0.0536
179 BRAIN NATRIURETIC PEPTIDE INCREASED 165 0.0535
180 LARGE INTESTINAL ULCER 145 0.0534
181 NECROTISING FASCIITIS 186 0.0527
182 BLOOD LACTATE DEHYDROGENASE INCREASED 834 0.0526
183 HEPATOSPLENOMEGALY 135 0.0525
184 MYOPATHY 454 0.0525
185 LIVER ABSCESS 170 0.0524
186 PUSTULAR PSORIASIS 180 0.0524
187 SEPTIC SHOCK 2271 0.0521
188 CYSTITIS HAEMORRHAGIC 210 0.0520
189 HYPOALBUMINAEMIA 405 0.0520
190 C-REACTIVE PROTEIN INCREASED 1885 0.0518
191 ADRENAL INSUFFICIENCY 627 0.0516
192 ENCEPHALITIS 357 0.0516
193 SQUAMOUS CELL CARCINOMA OF SKIN 310 0.0513
194 BACTERAEMIA 605 0.0509
195 UROSEPSIS 470 0.0509
196 LOWER RESPIRATORY TRACT INFECTION 2315 0.0509
197 JOINT RANGE OF MOTION DECREASED 680 0.0507
198 ACUTE RESPIRATORY DISTRESS SYNDROME 895 0.0506
199 INTERSTITIAL LUNG DISEASE 2439 0.0503
200 LUNG ADENOCARCINOMA 151 0.0501
201 MULTIPLE-DRUG RESISTANCE 153 0.0493
202 ERYSIPELAS 245 0.0487
203 MATERNAL EXPOSURE TIMING UNSPECIFIED 183 0.0487
204 FEBRILE NEUTROPENIA 3200 0.0482
205 VASCULITIS 561 0.0481
206 BRONCHIECTASIS 324 0.0480
207 IMMUNE THROMBOCYTOPENIA 220 0.0480
208 INFLAMMATORY MARKER INCREASED 237 0.0478
209 SKIN NECROSIS 248 0.0478
210 LARGE INTESTINE PERFORATION 331 0.0476
211 TOXIC EPIDERMAL NECROLYSIS 720 0.0474
212 GRANULOMA 163 0.0470
213 PLEURISY 279 0.0469
214 SUBCUTANEOUS ABSCESS 223 0.0465
215 PULMONARY FIBROSIS 888 0.0462
216 HYPERCHOLESTEROLAEMIA 446 0.0461
217 GESTATIONAL DIABETES 220 0.0461
218 AUTOIMMUNE HAEMOLYTIC ANAEMIA 158 0.0461
219 PYELONEPHRITIS 399 0.0460
220 POLYMYALGIA RHEUMATICA 146 0.0459
221 PANCYTOPENIA 2512 0.0449
222 NEPHROPATHY TOXIC 502 0.0447
223 FUNGAL SKIN INFECTION 180 0.0445
224 POLYARTHRITIS 234 0.0443
225 GLOSSODYNIA 993 0.0443
226 LEUKOENCEPHALOPATHY 165 0.0443
227 PROSTATE CANCER METASTATIC 148 0.0443
228 NEPHRITIS 147 0.0440
229 HYDRONEPHROSIS 329 0.0439
230 SYSTEMIC LUPUS ERYTHEMATOSUS 1557 0.0438
231 RHINOVIRUS INFECTION 170 0.0436
232 MYASTHENIA GRAVIS 352 0.0435
233 THERAPY PARTIAL RESPONDER 678 0.0434
234 CHOLANGITIS 268 0.0432
235 OBESITY 682 0.0428
236 PNEUMONIA VIRAL 135 0.0423
237 LUNG INFILTRATION 374 0.0423
238 LIVER INJURY 1035 0.0421
239 LEUKOPENIA 2085 0.0416
240 MYOSITIS 373 0.0415
241 SEPSIS 4630 0.0415
242 PULMONARY ALVEOLAR HAEMORRHAGE 232 0.0413
243 LOWER LIMB FRACTURE 789 0.0410
244 SCIATICA 654 0.0410
245 PARADOXICAL DRUG REACTION 150 0.0407
246 WOUND DEHISCENCE 136 0.0402
247 THERAPY NON-RESPONDER 1809 0.0402
248 RESPIRATORY FAILURE 2933 0.0402
249 DEAFNESS NEUROSENSORY 132 0.0401
250 IMMUNE-MEDIATED ENTEROCOLITIS 147 0.0399
251 HEPATIC FUNCTION ABNORMAL 1487 0.0398
252 MYELODYSPLASTIC SYNDROME 576 0.0398
253 PREMATURE DELIVERY 632 0.0397
254 WOUND 1109 0.0396
255 REBOUND EFFECT 448 0.0396
256 GASTROENTERITIS 575 0.0394
257 IMPAIRED HEALING 1284 0.0391
258 CANDIDA INFECTION 659 0.0390
259 CYTOPENIA 477 0.0389
260 ORAL CANDIDIASIS 511 0.0388
261 CUTANEOUS VASCULITIS 141 0.0386
262 PNEUMOTHORAX 612 0.0386
263 IRRITABLE BOWEL SYNDROME 826 0.0385
264 BONE MARROW FAILURE 782 0.0384
265 BASAL CELL CARCINOMA 591 0.0378
266 GASTROINTESTINAL PERFORATION 157 0.0377
267 MULTI-ORGAN FAILURE 650 0.0376
268 TUBULOINTERSTITIAL NEPHRITIS 698 0.0372
269 ILEUS PARALYTIC 166 0.0372
270 FIBROMYALGIA 895 0.0368
271 SPINAL COMPRESSION FRACTURE 304 0.0367
272 APLASTIC ANAEMIA 192 0.0367
273 ABDOMINAL ABSCESS 162 0.0366
274 LIVER DISORDER 1622 0.0365
275 PREMATURE BABY 1087 0.0361
276 POLYNEUROPATHY 429 0.0358
277 POSTOPERATIVE WOUND INFECTION 240 0.0355
278 PROTEINURIA 672 0.0353
279 HYPERURICAEMIA 145 0.0352
280 SERUM FERRITIN INCREASED 186 0.0352
281 AGRANULOCYTOSIS 653 0.0351
282 BLEPHAROSPASM 220 0.0349
283 IRON DEFICIENCY ANAEMIA 322 0.0348
284 GRIP STRENGTH DECREASED 307 0.0348
285 NECROSIS 194 0.0348
286 ABDOMINAL TENDERNESS 173 0.0348
287 OLIGURIA 216 0.0348
288 SMALL FOR DATES BABY 171 0.0344
289 SHOCK HAEMORRHAGIC 280 0.0344
290 BACTERIAL INFECTION 636 0.0341
291 PEMPHIGOID 257 0.0340
292 DRUG RESISTANCE 874 0.0340
293 SARCOIDOSIS 161 0.0339
294 AUTOIMMUNE HEPATITIS 235 0.0338
295 NORMAL NEWBORN 183 0.0336
296 RENAL IMPAIRMENT 2825 0.0336
297 ENDOPHTHALMITIS 200 0.0333
298 LEFT VENTRICULAR HYPERTROPHY 142 0.0331
299 HAEMOLYTIC ANAEMIA 297 0.0331
300 DRUG ERUPTION 585 0.0330
301 OSTEONECROSIS 1072 0.0326
302 CONCOMITANT DISEASE AGGRAVATED 201 0.0325
303 HYDROCEPHALUS 176 0.0323
304 HERPES VIRUS INFECTION 186 0.0323
305 GAMMA-GLUTAMYLTRANSFERASE INCREASED 715 0.0322
306 GUILLAIN-BARRE SYNDROME 156 0.0322
307 TONSILLITIS 166 0.0318
308 FEBRILE BONE MARROW APLASIA 135 0.0317
309 ANURIA 273 0.0317
310 ABSCESS LIMB 135 0.0316
311 PURPURA 280 0.0316
312 CLOSTRIDIUM DIFFICILE COLITIS 335 0.0316
313 PNEUMONITIS 856 0.0314
314 RASH VESICULAR 152 0.0314
315 FEMORAL NECK FRACTURE 161 0.0314
316 HYPERTRIGLYCERIDAEMIA 183 0.0312
317 EXOSTOSIS 285 0.0312
318 PULMONARY HAEMORRHAGE 244 0.0312
319 DUODENAL ULCER 220 0.0312
320 MENINGITIS 208 0.0311
321 HYPERCALCAEMIA 384 0.0311
322 CONTRAINDICATED PRODUCT ADMINISTERED 940 0.0310
323 DISEASE RECURRENCE 1469 0.0309
324 TYPE 2 DIABETES MELLITUS 1037 0.0308
325 PREMATURE LABOUR 174 0.0307
326 SPLENOMEGALY 360 0.0307
327 CACHEXIA 158 0.0307
328 STAPHYLOCOCCAL INFECTION 1009 0.0306
329 SECOND PRIMARY MALIGNANCY 254 0.0305
330 CEREBRAL INFARCTION 741 0.0303
331 ACUTE HEPATIC FAILURE 414 0.0303
332 TENDON RUPTURE 374 0.0303
333 LUPUS-LIKE SYNDROME 274 0.0302
334 DIARRHOEA HAEMORRHAGIC 282 0.0301
335 PERIPHERAL SENSORY NEUROPATHY 176 0.0301
336 SQUAMOUS CELL CARCINOMA 283 0.0300
337 OSTEOPOROSIS 1236 0.0300
338 PRESCRIBED OVERDOSE 581 0.0300
339 RALES 174 0.0299
340 HYPERGLYCAEMIA 1090 0.0299
341 ANAL ABSCESS 161 0.0298
342 NIGHT SWEATS 962 0.0298
343 HAEMATOTOXICITY 283 0.0298
344 INFLAMMATION 1537 0.0298
345 ILEUS 369 0.0297
346 SUBARACHNOID HAEMORRHAGE 302 0.0296
347 INTESTINAL PERFORATION 332 0.0295
348 NEPHROGENIC ANAEMIA 137 0.0295
349 LYMPHOMA 457 0.0295
350 CYTOKINE RELEASE SYNDROME 590 0.0294
351 ACUTE MYELOID LEUKAEMIA 458 0.0294
352 ENTERITIS 188 0.0293
353 HEPATIC FAILURE 885 0.0293
354 PRE-ECLAMPSIA 139 0.0292
355 SKIN ULCER 755 0.0292
356 UVEITIS 396 0.0292
357 METASTASES TO LYMPH NODES 197 0.0292
358 GENERAL PHYSICAL HEALTH DETERIORATION 3372 0.0291
359 OEDEMA 1570 0.0289
360 RENAL TUBULAR NECROSIS 283 0.0288
361 COMPRESSION FRACTURE 154 0.0287
362 LEFT VENTRICULAR DYSFUNCTION 192 0.0286
363 ALANINE AMINOTRANSFERASE INCREASED 1757 0.0286
364 MUCOSAL INFLAMMATION 748 0.0285
365 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 292 0.0284
366 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 251 0.0284
367 CHOLECYSTITIS ACUTE 160 0.0282
368 DRUG LEVEL INCREASED 467 0.0282
369 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1538 0.0280
370 CIRCULATORY COLLAPSE 477 0.0280
371 JOINT DISLOCATION 296 0.0280
372 PATHOGEN RESISTANCE 255 0.0279
373 HAEMOLYSIS 216 0.0279
374 INFUSION RELATED REACTION 1849 0.0279
375 PETECHIAE 291 0.0279
376 BLOOD ALBUMIN DECREASED 220 0.0277
377 GLUCOSE TOLERANCE IMPAIRED 164 0.0277
378 MELAENA 609 0.0276
379 HERPES ZOSTER 1589 0.0276
380 EOSINOPHILIA 484 0.0276
381 THROMBOCYTOPENIA 3076 0.0275
382 LUNG DISORDER 1342 0.0274
383 HEPATITIS 700 0.0273
384 DEVICE RELATED INFECTION 421 0.0273
385 STREPTOCOCCAL INFECTION 152 0.0273
386 WHEEZING 1618 0.0273
387 MATERNAL EXPOSURE DURING PREGNANCY 2432 0.0273
388 PLEURAL EFFUSION 1658 0.0272
389 HYPOKALAEMIA 1257 0.0272
390 HYPERTRANSAMINASAEMIA 189 0.0271
391 COLITIS ULCERATIVE 1214 0.0271
392 HEPATITIS ACUTE 176 0.0271
393 ULCER HAEMORRHAGE 183 0.0270
394 OSTEONECROSIS OF JAW 668 0.0270
395 RENAL CELL CARCINOMA 132 0.0270
396 TREATMENT FAILURE 2233 0.0269
397 HAEMODIALYSIS 226 0.0269
398 NAIL DISORDER 235 0.0268
399 ABSCESS 428 0.0268
400 GASTRIC ULCER 508 0.0267
401 ACIDOSIS 203 0.0265
402 HYPERBILIRUBINAEMIA 275 0.0265
403 BLOOD CREATININE INCREASED 1730 0.0265
404 PERITONITIS 546 0.0263
405 DELIRIUM 912 0.0263
406 OSTEOARTHRITIS 1112 0.0262
407 PATHOLOGICAL FRACTURE 133 0.0262
408 RENAL CYST 208 0.0262
409 DRUG-INDUCED LIVER INJURY 819 0.0261
410 ASPARTATE AMINOTRANSFERASE INCREASED 1379 0.0259
411 RESPIRATORY TRACT INFECTION 675 0.0259
412 ERYTHEMA MULTIFORME 240 0.0257
413 PANCREATITIS ACUTE 576 0.0256
414 PNEUMONIA ASPIRATION 640 0.0256
415 INTESTINAL ISCHAEMIA 141 0.0256
416 NEUTROPENIA 3479 0.0256
417 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 658 0.0255
418 OSTEOMYELITIS 463 0.0255
419 PRESCRIBED UNDERDOSE 510 0.0255
420 BLISTER 1430 0.0254
421 BLOOD ALKALINE PHOSPHATASE INCREASED 632 0.0254
422 STOMATITIS 1537 0.0253
423 NEUTROPHILIA 144 0.0253
424 ASCITES 741 0.0252
425 HIP ARTHROPLASTY 386 0.0252
426 SKIN ATROPHY 145 0.0252
427 URINE OUTPUT DECREASED 220 0.0251
428 BLOOD UREA INCREASED 420 0.0251
429 TACHYPNOEA 340 0.0250
430 LEUKOCYTOSIS 452 0.0250
431 VENTRICULAR SEPTAL DEFECT 143 0.0249
432 TRANSAMINASES INCREASED 553 0.0248
433 PYREXIA 8576 0.0248
434 PSORIATIC ARTHROPATHY 1004 0.0247
435 ELECTROLYTE IMBALANCE 287 0.0247
436 CARDIAC FAILURE ACUTE 164 0.0246
437 INFECTION 3554 0.0245
438 DISEASE PROGRESSION 2896 0.0245
439 MOUTH ULCERATION 515 0.0244
440 RETINAL HAEMORRHAGE 174 0.0244
441 ATELECTASIS 236 0.0244
442 APHTHOUS ULCER 189 0.0243
443 RETINAL DETACHMENT 224 0.0243
444 LYMPHADENOPATHY 862 0.0243
445 PULMONARY TOXICITY 172 0.0243
446 COLITIS 916 0.0241
447 HEPATIC ENCEPHALOPATHY 225 0.0241
448 HYPERKALAEMIA 839 0.0239
449 FOOT DEFORMITY 263 0.0237
450 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 184 0.0237
451 HAEMATURIA 808 0.0236
452 RHEUMATOID ARTHRITIS 2673 0.0235
453 BREAST CANCER STAGE II 195 0.0234
454 BRAIN OEDEMA 294 0.0233
455 SKIN INFECTION 260 0.0232
456 LYMPHOCYTE COUNT DECREASED 409 0.0231
457 CELLULITIS 1165 0.0231
458 MYOCARDIAL ISCHAEMIA 263 0.0231
459 RHINITIS 186 0.0230
460 TRICUSPID VALVE INCOMPETENCE 183 0.0230
461 MYOCARDITIS 262 0.0228
462 RESPIRATORY SYNCYTIAL VIRUS INFECTION 199 0.0228
463 EXPOSURE DURING PREGNANCY 1413 0.0227
464 JAUNDICE 609 0.0226
465 NEUTROPHIL COUNT DECREASED 922 0.0226
466 HEPATOTOXICITY 503 0.0226
467 HEPATOMEGALY 222 0.0226
468 LIVER FUNCTION TEST ABNORMAL 656 0.0225
469 HYPONATRAEMIA 1269 0.0225
470 IMMUNODEFICIENCY 335 0.0225
471 SKIN MASS 150 0.0224
472 EOSINOPHIL COUNT INCREASED 187 0.0224
473 HEPATIC ENZYME INCREASED 1526 0.0224
474 CARDIOMEGALY 275 0.0223
475 JOINT EFFUSION 154 0.0223
476 WALKING AID USER 147 0.0223
477 ACUTE RESPIRATORY FAILURE 428 0.0222
478 PLATELET COUNT INCREASED 290 0.0222
479 HEMIPARESIS 376 0.0222
480 RESPIRATORY DISTRESS 612 0.0222
481 PNEUMONIA 7119 0.0220
482 THERAPEUTIC PRODUCT EFFECT DECREASED 983 0.0219
483 ALTERED STATE OF CONSCIOUSNESS 475 0.0219
484 OSTEOPENIA 332 0.0219
485 NEUROTOXICITY 382 0.0218
486 DRUG INTOLERANCE 2105 0.0218
487 TYPE 1 DIABETES MELLITUS 131 0.0217
488 ULCER 346 0.0217
489 CHOLESTASIS 417 0.0217
490 NEUTROPHIL COUNT INCREASED 222 0.0217
491 GASTRITIS 570 0.0216
492 WHITE BLOOD CELL COUNT INCREASED 830 0.0216
493 OBSTRUCTIVE AIRWAYS DISORDER 240 0.0216
494 GAIT INABILITY 721 0.0216
495 INTRAOCULAR PRESSURE INCREASED 275 0.0215
496 ANAEMIA 4094 0.0214
497 ARTHROPATHY 1191 0.0214
498 HEPATIC STEATOSIS 399 0.0214
499 RASH PUSTULAR 156 0.0214
500 MITRAL VALVE INCOMPETENCE 242 0.0214
501 GENERALISED OEDEMA 263 0.0212
502 DERMATITIS BULLOUS 153 0.0211
503 PROSTATIC SPECIFIC ANTIGEN INCREASED 291 0.0211
504 HYPOPHOSPHATAEMIA 156 0.0211
505 HYPERTHERMIA 161 0.0211
506 SHOCK 485 0.0211
507 HYPOXIA 742 0.0210
508 CORONAVIRUS INFECTION 139 0.0210
509 MUSCULOSKELETAL PAIN 1100 0.0210
510 DRUG INTERACTION 3328 0.0210
511 LUNG INFECTION 325 0.0209
512 STEVENS-JOHNSON SYNDROME 465 0.0209
513 ACUTE KIDNEY INJURY 3200 0.0209
514 POLYURIA 171 0.0209
515 CARDIAC FAILURE 1675 0.0208
516 BLOOD CHOLESTEROL INCREASED 971 0.0208
517 MATERNAL EXPOSURE BEFORE PREGNANCY 142 0.0208
518 RASH MACULO-PAPULAR 461 0.0207
519 TENDONITIS 320 0.0206
520 PRODUCT USE IN UNAPPROVED INDICATION 5117 0.0206
521 SKIN LESION 565 0.0206
522 BLOOD BILIRUBIN INCREASED 554 0.0205
523 RESPIRATORY DISORDER 612 0.0204
524 HAEMODYNAMIC INSTABILITY 155 0.0203
525 CHOLECYSTITIS 242 0.0203
526 MALNUTRITION 227 0.0203
527 CONDITION AGGRAVATED 6161 0.0202
528 COAGULOPATHY 335 0.0201
529 METASTASES TO LUNG 231 0.0200
530 UPPER GASTROINTESTINAL HAEMORRHAGE 335 0.0199
531 HYPERLIPIDAEMIA 237 0.0198
532 SPINAL PAIN 232 0.0198
533 PLATELET COUNT DECREASED 2102 0.0197
534 COLITIS ISCHAEMIC 132 0.0195
535 HEPATIC CIRRHOSIS 367 0.0195
536 RENAL FAILURE CHRONIC 149 0.0194
537 GROIN PAIN 170 0.0193
538 FACIAL PARALYSIS 164 0.0192
539 DISCOMFORT 1171 0.0192
540 FOETAL EXPOSURE DURING PREGNANCY 1560 0.0192
541 RIGHT VENTRICULAR FAILURE 134 0.0191
542 PAPULE 134 0.0190
543 PHARYNGITIS 234 0.0188
544 PREGNANCY 375 0.0187
545 OFF LABEL USE 16111 0.0184
546 DIABETES MELLITUS 1396 0.0183
547 AORTIC ANEURYSM 139 0.0183
548 EMPHYSEMA 184 0.0182
549 GASTROINTESTINAL INFECTION 163 0.0182
550 PSYCHIATRIC SYMPTOM 134 0.0181
551 SENSATION OF FOREIGN BODY 153 0.0181
552 DYSPNOEA EXERTIONAL 682 0.0181
553 TOXIC SKIN ERUPTION 182 0.0181
554 PERICARDIAL EFFUSION 417 0.0180
555 ABORTION INDUCED 169 0.0179
556 HYPOMAGNESAEMIA 249 0.0179
557 MYELOSUPPRESSION 644 0.0179
558 HYPOCALCAEMIA 337 0.0178
559 PULMONARY EMBOLISM 1689 0.0178
560 FUNGAL INFECTION 590 0.0177
561 RENAL FAILURE ACUTE 747 0.0176
562 COVID-19 3088 0.0176
563 CARDIOMYOPATHY 260 0.0176
564 PULMONARY MASS 260 0.0174
565 PULMONARY CONGESTION 230 0.0174
566 HAEMATOMA 451 0.0174
567 OESOPHAGITIS 190 0.0174
568 INTENTIONAL PRODUCT USE ISSUE 1522 0.0174
569 FACIAL PAIN 155 0.0173
570 ARTERIOSCLEROSIS 163 0.0173
571 HEMIPLEGIA 144 0.0173
572 TENDERNESS 179 0.0172
573 END STAGE RENAL DISEASE 313 0.0171
574 HAEMATEMESIS 435 0.0171
575 BODY TEMPERATURE INCREASED 350 0.0171
576 MOBILITY DECREASED 1232 0.0171
577 METABOLIC ACIDOSIS 548 0.0171
578 TACHYCARDIA 1521 0.0171
579 METASTASES TO LIVER 300 0.0171
580 ACUTE CORONARY SYNDROME 141 0.0170
581 ORAL HERPES 332 0.0170
582 CAESAREAN SECTION 198 0.0170
583 BRONCHOSPASM 242 0.0169
584 DECUBITUS ULCER 138 0.0169
585 URINARY TRACT INFECTION 2884 0.0169
586 ENCEPHALOPATHY 415 0.0169
587 PULMONARY HYPERTENSION 351 0.0168
588 ASTHMA 1903 0.0168
589 JOINT SWELLING 2031 0.0168
590 EPILEPSY 513 0.0168
591 OEDEMA PERIPHERAL 2032 0.0167
592 TASTE DISORDER 337 0.0166
593 DEEP VEIN THROMBOSIS 1076 0.0165
594 HAEMOPTYSIS 460 0.0165
595 EYE INFLAMMATION 157 0.0164
596 VENTRICULAR TACHYCARDIA 271 0.0164
597 GASTROINTESTINAL DISORDER 1467 0.0164
598 HYPERTHYROIDISM 237 0.0164
599 GLAUCOMA 314 0.0163
600 KNEE ARTHROPLASTY 342 0.0162
601 CARDIOTOXICITY 144 0.0161
602 OPTIC NEURITIS 146 0.0161
603 CATARACT 952 0.0160
604 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 274 0.0160
605 CEREBRAL HAEMORRHAGE 572 0.0160
606 ACUTE MYOCARDIAL INFARCTION 471 0.0160
607 NEPHROPATHY 148 0.0158
608 CLOSTRIDIUM DIFFICILE INFECTION 346 0.0158
609 HYPERTENSIVE CRISIS 176 0.0158
610 EAR PAIN 307 0.0158
611 SUDDEN DEATH 167 0.0158
612 GENERALISED TONIC-CLONIC SEIZURE 261 0.0158
613 LIP SWELLING 525 0.0157
614 EMBOLISM 130 0.0156
615 SPINAL OSTEOARTHRITIS 137 0.0156
616 LIVER FUNCTION TEST INCREASED 334 0.0155
617 SWELLING 1452 0.0155
618 SINUS TACHYCARDIA 220 0.0155
619 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1097 0.0154
620 IMMUNE SYSTEM DISORDER 203 0.0154
621 ROAD TRAFFIC ACCIDENT 644 0.0154
622 ANGIOEDEMA 679 0.0153
623 DERMATITIS ALLERGIC 193 0.0153
624 FACE OEDEMA 258 0.0153
625 DRUG LEVEL DECREASED 155 0.0152
626 PRODUCTIVE COUGH 727 0.0152
627 SPINAL FRACTURE 304 0.0152
628 MUSCLE ATROPHY 191 0.0151
629 HEPATITIS C 182 0.0151
630 FISTULA 169 0.0150
631 HYPERTENSION 3181 0.0150
632 NO THERAPEUTIC RESPONSE 183 0.0150
633 UPPER RESPIRATORY TRACT INFECTION 693 0.0150
634 DIVERTICULITIS 414 0.0149
635 RENAL FAILURE 1971 0.0148
636 ANAPHYLACTIC REACTION 820 0.0148
637 ABDOMINAL PAIN 3447 0.0148
638 CYANOSIS 233 0.0148
639 APPENDICITIS 137 0.0147
640 CARDIOGENIC SHOCK 210 0.0146
641 HYPOTHYROIDISM 467 0.0146
642 RECTAL HAEMORRHAGE 628 0.0146
643 CONJUNCTIVITIS 271 0.0146
644 HAEMOGLOBIN DECREASED 1500 0.0146
645 ATRIAL FIBRILLATION 1420 0.0146
646 CONTUSION 1399 0.0145
647 NODULE 189 0.0145
648 THERAPEUTIC RESPONSE DECREASED 876 0.0144
649 METASTASES TO BONE 237 0.0144
650 MUSCULAR WEAKNESS 1641 0.0144
651 STATUS EPILEPTICUS 163 0.0144
652 GLOMERULAR FILTRATION RATE DECREASED 177 0.0144
653 VIRAL INFECTION 477 0.0143
654 ATAXIA 170 0.0143
655 HAEMATOCHEZIA 790 0.0143
656 GASTROINTESTINAL HAEMORRHAGE 1191 0.0142
657 CONFUSIONAL STATE 2303 0.0142
658 MUSCULOSKELETAL STIFFNESS 1240 0.0141
659 PALLOR 380 0.0140
660 DECREASED IMMUNE RESPONSIVENESS 137 0.0139
661 SLEEP DISORDER 983 0.0139
662 PSYCHOTIC DISORDER 410 0.0139
663 FREQUENT BOWEL MOVEMENTS 374 0.0138
664 DEPRESSED LEVEL OF CONSCIOUSNESS 545 0.0138
665 BEDRIDDEN 181 0.0138
666 ILL-DEFINED DISORDER 831 0.0137
667 EYELID PTOSIS 139 0.0137
668 HEPATOCELLULAR INJURY 192 0.0135
669 COLON CANCER 201 0.0135
670 URINARY RETENTION 450 0.0135
671 MANIA 220 0.0134
672 PHOTOPHOBIA 251 0.0133
673 SECRETION DISCHARGE 167 0.0133
674 DIPLOPIA 346 0.0133
675 HAEMATOCRIT DECREASED 264 0.0133
676 PULMONARY OEDEMA 593 0.0132
677 SWELLING FACE 859 0.0132
678 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 688 0.0132
679 CORONARY ARTERY DISEASE 398 0.0131
680 PHOTOSENSITIVITY REACTION 217 0.0131
681 ANOREXIA 169 0.0131
682 MASS 183 0.0131
683 WHITE BLOOD CELL COUNT DECREASED 1418 0.0131
684 INJURY 919 0.0131
685 DRY MOUTH 1058 0.0130
686 VISUAL ACUITY REDUCED 433 0.0130
687 MEDICATION ERROR 722 0.0130
688 FEMUR FRACTURE 402 0.0130
689 DECREASED APPETITE 2984 0.0128
690 SWOLLEN TONGUE 401 0.0128
691 DYSPNOEA 7217 0.0127
692 HIATUS HERNIA 165 0.0127
693 METASTASES TO CENTRAL NERVOUS SYSTEM 164 0.0127
694 ANGINA PECTORIS 364 0.0127
695 NEUROPATHY PERIPHERAL 1206 0.0127
696 PANCREATITIS 668 0.0126
697 MALIGNANT MELANOMA 169 0.0126
698 SMALL INTESTINAL OBSTRUCTION 155 0.0126
699 VENTRICULAR FIBRILLATION 139 0.0125
700 CHEST PAIN 2310 0.0125
701 BONE DISORDER 226 0.0124
702 DYSURIA 453 0.0123
703 FOOT FRACTURE 233 0.0123
704 PERIPHERAL SWELLING 1890 0.0123
705 BLOOD POTASSIUM INCREASED 196 0.0121
706 SKIN REACTION 170 0.0121
707 SINUSITIS 1235 0.0120
708 ASPIRATION 131 0.0119
709 MALIGNANT NEOPLASM PROGRESSION 1224 0.0119
710 ARTHRITIS 940 0.0119
711 GOUT 214 0.0119
712 NEOPLASM PROGRESSION 410 0.0118
713 ISCHAEMIC STROKE 210 0.0118
714 ARRHYTHMIA 557 0.0118
715 OXYGEN SATURATION DECREASED 657 0.0117
716 EJECTION FRACTION DECREASED 180 0.0116
717 BLOOD CREATINE PHOSPHOKINASE INCREASED 333 0.0116
718 LETHARGY 664 0.0115
719 RHABDOMYOLYSIS 481 0.0115
720 RENAL DISORDER 537 0.0115
721 EYE PAIN 650 0.0115
722 NEOPLASM 132 0.0115
723 SKIN DISORDER 383 0.0115
724 ANAPHYLACTIC SHOCK 292 0.0113
725 CENTRAL NERVOUS SYSTEM LESION 155 0.0113
726 DERMATITIS 235 0.0112
727 DYSARTHRIA 422 0.0112
728 VOMITING 5252 0.0112
729 INTERNATIONAL NORMALISED RATIO INCREASED 318 0.0111
730 DIABETIC KETOACIDOSIS 267 0.0111
731 CARDIAC ARREST 916 0.0111
732 BLINDNESS UNILATERAL 156 0.0110
733 FRACTURE 209 0.0110
734 RIB FRACTURE 227 0.0110
735 BRONCHITIS 814 0.0110
736 HYPERSENSITIVITY 2038 0.0110
737 ORTHOSTATIC HYPOTENSION 190 0.0109
738 HYPOAESTHESIA 1631 0.0109
739 HYPOPHAGIA 278 0.0109
740 BLINDNESS 443 0.0109
741 SUBDURAL HAEMATOMA 155 0.0108
742 SENSORY DISTURBANCE 173 0.0108
743 TOXICITY TO VARIOUS AGENTS 1809 0.0107
744 CARDIOVASCULAR DISORDER 271 0.0107
745 DIARRHOEA 6884 0.0107
746 CARDIO-RESPIRATORY ARREST 445 0.0106
747 INTERVERTEBRAL DISC PROTRUSION 232 0.0106
748 COUGH 2975 0.0106
749 DISORIENTATION 419 0.0106
750 ARTHRALGIA 4379 0.0105
751 RASH PRURITIC 567 0.0105
752 CHOLELITHIASIS 343 0.0104
753 URTICARIA 1747 0.0104
754 DIABETES MELLITUS INADEQUATE CONTROL 183 0.0103
755 HAEMORRHAGE INTRACRANIAL 154 0.0103
756 RASH 4488 0.0103
757 HALLUCINATION, VISUAL 217 0.0103
758 ALOPECIA 2013 0.0102
759 NASOPHARYNGITIS 1886 0.0102
760 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 491 0.0102
761 DISABILITY 202 0.0102
762 ORAL PAIN 228 0.0102
763 SYNCOPE 1016 0.0101
764 CHILLS 1190 0.0101
765 APHASIA 304 0.0101
766 HAEMORRHOIDS 196 0.0100
767 CYSTITIS 318 0.0100
768 DRUG INEFFECTIVE 13094 0.0099
769 ABDOMINAL PAIN UPPER 2045 0.0099
770 NERVOUS SYSTEM DISORDER 310 0.0099
771 DYSPHAGIA 941 0.0099
772 BLOOD POTASSIUM DECREASED 298 0.0099
773 HYPOGLYCAEMIA 479 0.0099
774 ABORTION SPONTANEOUS 395 0.0098
775 MALAISE 4319 0.0098
776 JOINT STIFFNESS 258 0.0098
777 BLOOD SODIUM DECREASED 185 0.0098
778 EAR INFECTION 261 0.0098
779 PRODUCT USE ISSUE 1836 0.0098
780 HYPOKINESIA 141 0.0097
781 CHRONIC KIDNEY DISEASE 736 0.0097
782 TRANSIENT ISCHAEMIC ATTACK 326 0.0097
783 FLUID RETENTION 490 0.0096
784 RED BLOOD CELL COUNT DECREASED 274 0.0096
785 AMNESIA 623 0.0096
786 ABDOMINAL PAIN LOWER 242 0.0096
787 ERYTHEMA 1967 0.0096
788 URINARY INCONTINENCE 282 0.0095
789 PARALYSIS 136 0.0095
790 PRODUCT PRESCRIBING ERROR 226 0.0095
791 INFLUENZA 1051 0.0094
792 PARAESTHESIA 1479 0.0094
793 RESTLESSNESS 344 0.0094
794 DEHYDRATION 1249 0.0094
795 HYPOTENSION 1876 0.0093
796 RASH GENERALISED 242 0.0093
797 WEIGHT INCREASED 2084 0.0093
798 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 272 0.0093
799 RASH ERYTHEMATOUS 442 0.0092
800 COMA 439 0.0092
801 BRADYCARDIA 485 0.0091
802 COGNITIVE DISORDER 427 0.0091
803 ABDOMINAL DISCOMFORT 1533 0.0091
804 NEURALGIA 221 0.0091
805 PULMONARY ARTERIAL HYPERTENSION 131 0.0090
806 LACTIC ACIDOSIS 292 0.0090
807 DRUG EXPOSURE DURING PREGNANCY 304 0.0089
808 TINNITUS 409 0.0089
809 MUSCULOSKELETAL CHEST PAIN 137 0.0088
810 BONE PAIN 510 0.0087
811 POST PROCEDURAL COMPLICATION 167 0.0087
812 MYALGIA 1461 0.0086
813 WEIGHT DECREASED 2394 0.0086
814 BLOOD PRESSURE DECREASED 568 0.0085
815 TREATMENT NONCOMPLIANCE 466 0.0085
816 CHEST DISCOMFORT 872 0.0085
817 THIRST 152 0.0085
818 DYSPEPSIA 837 0.0085
819 PRODUCT PRESCRIBING ISSUE 185 0.0085
820 PLASMA CELL MYELOMA 330 0.0084
821 LABORATORY TEST ABNORMAL 248 0.0084
822 PAIN IN JAW 237 0.0084
823 DEAFNESS 218 0.0083
824 VISUAL IMPAIRMENT 1030 0.0083
825 CHROMATURIA 186 0.0082
826 ASTHENIA 3096 0.0082
827 PAIN IN EXTREMITY 2414 0.0082
828 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 138 0.0081
829 RASH PAPULAR 182 0.0081
830 SLEEP APNOEA SYNDROME 154 0.0081
831 INTESTINAL OBSTRUCTION 304 0.0081
832 GASTROOESOPHAGEAL REFLUX DISEASE 649 0.0081
833 FEELING HOT 493 0.0080
834 HALLUCINATION 602 0.0080
835 FEELING COLD 222 0.0080
836 COLD SWEAT 140 0.0079
837 BACK PAIN 1825 0.0078
838 PRESYNCOPE 190 0.0078
839 SKIN CANCER 168 0.0078
840 KIDNEY INFECTION 153 0.0078
841 FAECES DISCOLOURED 169 0.0078
842 HAEMORRHAGE 813 0.0078
843 DEPRESSED MOOD 410 0.0077
844 ECZEMA 405 0.0077
845 THROMBOSIS 619 0.0077
846 GAIT DISTURBANCE 1469 0.0077
847 PALPITATIONS 887 0.0076
848 NECK PAIN 423 0.0076
849 EPISTAXIS 566 0.0076
850 HEADACHE 4735 0.0075
851 DYSPHONIA 440 0.0075
852 LOSS OF CONSCIOUSNESS 957 0.0075
853 OROPHARYNGEAL PAIN 682 0.0074
854 MIGRAINE 702 0.0073
855 MUSCLE SPASMS 1349 0.0073
856 RASH MACULAR 257 0.0073
857 TOOTHACHE 133 0.0073
858 ADVERSE DRUG REACTION 649 0.0072
859 VERTIGO 438 0.0072
860 EYE DISORDER 236 0.0072
861 NAUSEA 5639 0.0071
862 DEPRESSION 1617 0.0071
863 PRURITUS 2716 0.0071
864 INSOMNIA 1874 0.0070
865 FALL 2338 0.0070
866 CONSTIPATION 1527 0.0070
867 LUNG NEOPLASM MALIGNANT 286 0.0070
868 LOCALISED INFECTION 168 0.0069
869 BLOOD PRESSURE SYSTOLIC INCREASED 135 0.0069
870 CONVULSION 395 0.0069
871 DYSSTASIA 201 0.0069
872 VISION BLURRED 945 0.0069
873 EYE SWELLING 256 0.0069
874 MOOD SWINGS 219 0.0069
875 HYPERHIDROSIS 884 0.0069
876 ABDOMINAL DISTENSION 715 0.0068
877 DIZZINESS 3415 0.0068
878 MEMORY IMPAIRMENT 940 0.0068
879 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 159 0.0068
880 ADVERSE EVENT 627 0.0068
881 FATIGUE 5282 0.0068
882 SPEECH DISORDER 355 0.0068
883 SEIZURE 779 0.0067
884 MENTAL DISORDER 293 0.0067
885 TREMOR 1087 0.0065
886 PAIN 3995 0.0065
887 DRY EYE 324 0.0065
888 DISTURBANCE IN ATTENTION 350 0.0065
889 DRUG EFFECT INCOMPLETE 233 0.0064
890 AGITATION 471 0.0064
891 EATING DISORDER 136 0.0064
892 MENTAL STATUS CHANGES 174 0.0063
893 GASTRIC CANCER 158 0.0062
894 LACRIMATION INCREASED 187 0.0062
895 RESPIRATORY ARREST 170 0.0062
896 HIP FRACTURE 196 0.0061
897 POOR QUALITY SLEEP 131 0.0061
898 ELECTROCARDIOGRAM QT PROLONGED 217 0.0060
899 MOVEMENT DISORDER 193 0.0060
900 PAIN OF SKIN 160 0.0059
901 SKIN EXFOLIATION 500 0.0059
902 BLOOD PRESSURE INCREASED 904 0.0059
903 POLLAKIURIA 245 0.0059
904 BLOOD PRESSURE FLUCTUATION 141 0.0059
905 DEMENTIA 164 0.0059
906 MUSCLE TWITCHING 135 0.0059
907 RENAL INJURY 173 0.0058
908 LIMB DISCOMFORT 180 0.0058
909 SKIN DISCOLOURATION 266 0.0058
910 ABNORMAL BEHAVIOUR 229 0.0058
911 OCULAR HYPERAEMIA 274 0.0058
912 THROAT TIGHTNESS 155 0.0057
913 AGGRESSION 286 0.0057
914 ANXIETY 1624 0.0057
915 NEPHROLITHIASIS 259 0.0056
916 CARDIAC DISORDER 523 0.0056
917 MYOCARDIAL INFARCTION 970 0.0056
918 ABASIA 137 0.0055
919 CARDIAC FAILURE CONGESTIVE 444 0.0055
920 SOMNOLENCE 1110 0.0055
921 HEART RATE INCREASED 535 0.0054
922 ACCIDENTAL OVERDOSE 197 0.0054
923 UNRESPONSIVE TO STIMULI 138 0.0053
924 RHINORRHOEA 336 0.0052
925 LIMB INJURY 140 0.0051
926 EYE IRRITATION 295 0.0051
927 NEOPLASM MALIGNANT 340 0.0051
928 BALANCE DISORDER 438 0.0051
929 MOOD ALTERED 138 0.0051
930 EYE PRURITUS 166 0.0049
931 UNDERDOSE 357 0.0049
932 SUICIDAL IDEATION 447 0.0049
933 NASAL CONGESTION 283 0.0048
934 INFLUENZA LIKE ILLNESS 395 0.0048
935 NIGHTMARE 164 0.0047
936 IRRITABILITY 281 0.0047
937 INTENTIONAL PRODUCT MISUSE 408 0.0047
938 CRYING 166 0.0046
939 GASTRIC DISORDER 152 0.0044
940 DEATH 3784 0.0044
941 HEAD INJURY 137 0.0043
942 PSORIASIS 551 0.0042
943 FLATULENCE 237 0.0042
944 PROSTATE CANCER 334 0.0041
945 ANGER 140 0.0041
946 HYPOACUSIS 178 0.0041
947 CEREBROVASCULAR ACCIDENT 697 0.0041
948 PANIC ATTACK 149 0.0041
949 HEART RATE DECREASED 143 0.0041
950 WITHDRAWAL SYNDROME 171 0.0041
951 DYSKINESIA 165 0.0041
952 FLUSHING 408 0.0040
953 BURNING SENSATION 279 0.0040
954 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 713 0.0040
955 HOT FLUSH 298 0.0040
956 DYSGEUSIA 280 0.0038
957 THROAT IRRITATION 159 0.0035
958 BLOOD GLUCOSE INCREASED 657 0.0035
959 SUICIDE ATTEMPT 209 0.0034
960 BREAST CANCER 320 0.0034
961 HOSPITALISATION 526 0.0034
962 SURGERY 199 0.0034
963 DRUG EFFECT DECREASED 171 0.0032
964 DRY SKIN 423 0.0032
965 FEELING ABNORMAL 734 0.0031
966 ILLNESS 310 0.0030
967 UNEVALUABLE EVENT 217 0.0029
968 ACNE 217 0.0029
969 DERMATITIS ATOPIC 146 0.0028
970 NO ADVERSE EVENT 472 0.0026
971 INJECTION SITE REACTION 178 0.0026
972 EMOTIONAL DISTRESS 311 0.0026
973 OVERDOSE 550 0.0025
974 THERAPY INTERRUPTED 182 0.0025
975 INTENTIONAL OVERDOSE 161 0.0025
976 DRUG ABUSE 193 0.0023
977 BLADDER CANCER 130 0.0022
978 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 156 0.0022
979 MULTIPLE SCLEROSIS RELAPSE 148 0.0022
980 PRODUCT QUALITY ISSUE 291 0.0021
981 SKIN BURNING SENSATION 139 0.0019
982 PRODUCT DOSE OMISSION ISSUE 557 0.0019
983 INCORRECT DOSE ADMINISTERED 378 0.0017
984 INJECTION SITE ERYTHEMA 196 0.0016
985 DRUG DEPENDENCE 237 0.0015
986 INJECTION SITE PAIN 331 0.0011
987 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 198 0.0010
988 DRUG DOSE OMISSION 134 0.0008